Evidence
Brain Pathol. 2024 Jan 12:e13238. doi: 10.1111/bpa.13238. Online ahead of print.
ABSTRACT
With the new era of disease-modifying therapies for neurodegenerative diseases, a novel approach for the molecular classification of neurodegenerative diseases is needed. In this research letter, there is a summary of the advances made in Alzheimer’s disease, Lewy body disorders, and progressive supranuclear palsy toward this classification.
PMID:38214380 | DOI:10.1111/bpa.13238
Add to Google Keep
Estimated reading time: 1 minute(s)
Latest: Psychiatryai.com #RAISR4D
Cool Evidence: Engaging Young People and Students in Real-World Evidence ☀️
Real-Time Evidence Search [Psychiatry]
AI Research [Andisearch.com]
Phenotype parallels protein seeding capacity in neurodegenerative diseases
🌐 90 Days
VR Related Evidence Matrix
- Huntingtin CAG repeats in neuropathologically confirmed tauopathies: Novel insights
- Ranking and filtering of neuropathology features in the machine learning evaluation of dementia studies
- Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
- Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
- Meeting report of the 20th International Congress of Neuropathology (ICN) 2023 in Berlin
- Revisiting the relevance of Hirano bodies in neurodegenerative diseases
- The complement system in neurodegenerative diseases
- Plastic compounds and liver diseases: Whether bisphenol A is the only culprit
- Disease and brain region specific immune response profiles in neurodegenerative diseases with pure and mixed protein pathologies
- Smell the smoke before one sees the fire-The oligosymptomatic prodromal phase of neurodegenerative diseases
- A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Bioactive Peptides
- Clinical Arterial Spin-Labeling MR Imaging to Screen for Typical and Atypical Neurodegenerative Disease in the New Era of Alzheimer Treatment
- Neurotoxicity of Pyrethroids in exacerbating neurodegenerative diseases: From animals' models to humans' studies
- Impact of genetic predisposition to late-onset neurodegenerative diseases on early life outcomes and brain structure
- Gastroesophageal reflux disease with 6 neurodegenerative and psychiatric disorders: Genetic correlations, causality, and potential molecular mechanisms
- Innate immune activation in neurodegenerative diseases
- Dissecting Parkinson's disease with long-read RNA-sequencing
- How can we manage progressive supranuclear palsy syndrome with pharmacotherapy?
- A comprehensive histomolecular characterization of meningioangiomatosis: Further evidence for a precursor neoplastic lesion
- Regulated cell death and its role in Alzheimer's disease and amyotrophic lateral sclerosis
- Disentangling and quantifying the relative cognitive impact of concurrent mixed neurodegenerative pathologies
- Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases
- The Role of Vitamin K in the Development of Neurodegenerative Diseases
- Transcriptomics of Human Brain Tissue in Parkinson's Disease: a Comparison of Bulk and Single-cell RNA Sequencing
- Are age-related neurodegenerative diseases caused by a lack of the diet-derived compound ergothioneine?
- The 37TrillionCells initiative for improving global healthcare via cell-based interception and precision medicine: focus on neurodegenerative diseases
- Using Drosophila amyloid toxicity models to study Alzheimer's disease
- Endo-lysosomal dysfunction in neurodegenerative diseases: opinion on current progress and future direction in the use of exosomes as biomarkers
- Exploring Psychosis in Neurodegenerative Dementia: Connecting Symptoms to Neurobiology
- When prion disease Isn't suspected: prion disease as the cause of terminal decline in chronic mixed dementia
- Anorexigenic neuropeptides as anti-obesity and neuroprotective agents
- Palliative Care Interventions for Persons With Neurodegenerative Disease: A Scoping Review of Clinical Trial Study Design Features
- The effects of cholesterol and statins on Parkinson's neuropathology: a narrative review
- Understanding exosomes: Part 2-Emerging leaders in regenerative medicine
- PPARs (Peroxisome Proliferator-activated Receptors) and Their Agonists in Alzheimer's Disease
- Distinctive whole-brain cell types predict tissue damage patterns in thirteen neurodegenerative conditions
- Aneuploidy is Linked to Neurological Phenotypes Through Oxidative Stress
- Skin-brain axis in Alzheimer's disease - Pathologic, diagnostic, and therapeutic implications: A Hypothetical Review
- Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19
- Cognitive impairment, neurodegenerative disorders, and olfactory impairment: A literature review
- The complexity of extracellular vesicles: Bridging the gap between cellular communication and neuropathology
- Therapeutic Potential Effect of Glycogen Synthase Kinase 3 Beta (GSK-3β) Inhibitors in Parkinson Disease: Exploring an Overlooked Avenue
- Novel method for classification of prion diseases by detecting PrPres signal patterns from formalin-fixed paraffin-embedded samples
- Nonpharmacological intervention therapies for dementia: potential break-even intervention price and savings for selected risk factors in the European healthcare system
- Genetic overlap between Alzheimer's disease and immune-mediated diseases: an atlas of shared genetic determinants and biological convergence
- TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43
- Association of Parkinson's disease to Parkinson's plus syndromes, Lewy body dementia, and Alzheimer's dementia
- Neuronal activity induces symmetry breaking in neurodegenerative disease spreading
- Linguistic changes in neurodegenerative diseases relate to clinical symptoms
- Targeting N-Methyl-d-Aspartate Receptors in Neurodegenerative Diseases
- NMDA receptor-mediated Ca2+ signaling: Impact on cell cycle regulation and the development of neurodegenerative diseases and cancer
- NMDA receptor-mediated Ca2+ signaling: Impact on cell cycle regulation and the development of neurodegenerative diseases and cancer
- Traumatic Brain Injury in Mice Generates Early-Stage Alzheimer's Disease Related Protein Pathology that Correlates with Neurobehavioral Deficits
- Pathogenic Potential of Eomesodermin-Expressing T-Helper Cells in Neurodegenerative Diseases
- Astrocytes in selective vulnerability to neurodegenerative disease
- The seeds of its regulation: natural antisense transcripts as single-gene control switches in neurodegenerative disorders
- Tau- and α-synuclein-targeted gold nanoparticles: applications, opportunities, and future outlooks in the diagnosis and therapy of neurodegenerative diseases
- Accumulation of neutral lipids in dystrophic neurites surrounding amyloid plaques in Alzheimer's disease
- Histologic tau lesions and magnetic resonance imaging biomarkers differ across two progressive supranuclear palsy variants
- Phytocannabinoids in neuromodulation: from omics to epigenetics
- Psychosis in Neurodegenerative Dementias: A Systematic Comparative Review
- Stem Cell Interventions in the Treatment of Alzheimer's Disease
- Emerging Role of ABC Transporters in Glia Cells in Health and Diseases of the Central Nervous System
- Artificial intelligence and open science in discovery of disease-modifying medicines for Alzheimer's disease
Evidence Blueprint
Phenotype parallels protein seeding capacity in neurodegenerative diseases
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Phenotype parallels protein seeding capacity in neurodegenerative diseases
🌐 365 Days
VR Related Evidence Matrix
- Induced pluripotent stem cell models as a tool to investigate and test fluid biomarkers in Alzheimer's disease and frontotemporal dementia
- Huntingtin CAG repeats in neuropathologically confirmed tauopathies: Novel insights
- Incidence and morphology of secondary TDP-43 proteinopathies: Part 2
- Secondary Protein Aggregates in Neurodegenerative Diseases: Almost the Rule Rather than the Exception
- Pathology of neurodegenerative disease for the general neurologist
- Ranking and filtering of neuropathology features in the machine learning evaluation of dementia studies
- Evaluating the performance of large language models: ChatGPT and Google Bard in generating differential diagnoses in clinicopathological conferences of neurodegenerative disorders
- Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
- Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside
- Postmortem neuropathology in COVID-19: An update
- Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
- Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
- A 3-year-old male with an extramedullary, intra- and extradural mass at T11-L1
- Meeting report of the 20th International Congress of Neuropathology (ICN) 2023 in Berlin
- Distribution of ferritin complex in the adult brain and altered composition in neuroferritinopathy due to a novel variant in the ferritin heavy chain gene FTH1 (c.409_410del; p.H137Lfs*4)
- Disentangling tau: One protein, many therapeutic approaches
- Patients with Neurodegenerative Proteinopathies Exhibit Altered Tryptophan Metabolism in the Serum and Cerebrospinal Fluid
- Revisiting the relevance of Hirano bodies in neurodegenerative diseases
- Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the Microbiome
- Announcing the Asian Oceanian Society of Neuropathology guidelines for Adapting Diagnostic Approaches for Practical Taxonomy in Resource-Restrained Regions (AOSNP-ADAPTR)
- The complement system in neurodegenerative diseases
- Getting to the heart of Lewy body disease
- A 53-year-old man with a 16-year history of asymmetrical proximal muscle weakness, facial muscle weakness, and scapular winging
- Abstracts of the 20th International Congress of Neuropathology Berlin, Germany, September 13 - 16, 2023
- Let Us Talk Money: Subjectively Reported Financial Performance of People Living with Neurodegenerative Diseases-A Systematic Review
- Plastic compounds and liver diseases: Whether bisphenol A is the only culprit
- Alpha-synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain
- Disease and brain region specific immune response profiles in neurodegenerative diseases with pure and mixed protein pathologies
- Targeted examination of amyloid beta and tau protein accumulation via positron emission tomography for the differential diagnosis of Alzheimer's disease based on the A/T(N) research framework
- Therapeutic Potential of Heterocyclic Compounds Targeting Mitochondrial Calcium Homeostasis and Signaling in Alzheimer's Disease and Parkinson's Disease
- Repercussion of Primary Nucleation Pathway: Dementia and Cognitive Impairment
- Smell the smoke before one sees the fire-The oligosymptomatic prodromal phase of neurodegenerative diseases
- A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Bioactive Peptides
- Molecular pathology of neurodegenerative diseases by cryo-EM of amyloids
- Clinical Arterial Spin-Labeling MR Imaging to Screen for Typical and Atypical Neurodegenerative Disease in the New Era of Alzheimer Treatment
- DistSNE: Distributed computing and online visualization of DNA methylation-based central nervous system tumor classification
- Neurotoxicity of Pyrethroids in exacerbating neurodegenerative diseases: From animals' models to humans' studies
- Elucidating distinct molecular signatures of Lewy body dementias
- Regional genetic correlations highlight relationships between neurodegenerative disease loci and the immune system
- Impact of genetic predisposition to late-onset neurodegenerative diseases on early life outcomes and brain structure
- Gastroesophageal reflux disease with 6 neurodegenerative and psychiatric disorders: Genetic correlations, causality, and potential molecular mechanisms
- Decreased DHA-containing phospholipids in the neocortex of dementia with Lewy bodies are associated with soluble Aβ42 , phosphorylated α-synuclein, and synaptopathology
- Rare neurovascular genetic and imaging markers across neurodegenerative diseases
- Morphology-based molecular classification of spinal cord ependymomas using deep neural networks
- Dissecting the Relationship Between Neuropsychiatric and Neurodegenerative Disorders
- The pontine diffuse midline glioma, EGFR-subtype with ependymal features: Yet another face of diffuse midline glioma, H3K27-altered
- Innate immune activation in neurodegenerative diseases
- Distribution of ubiquilin 2 and TDP-43 aggregates throughout the CNS in UBQLN2 p.T487I-linked amyotrophic lateral sclerosis and frontotemporal dementia
- Causal Association Between Sepsis and Neurodegenerative Diseases: A Bidirectional Two-Sample Mendelian Randomization Study
- Point/counterpoint: Should full agonist opioid medications be offered to hospitalized patients for management of opioid withdrawal?
- Cryo-EM structures of tau filaments from SH-SY5Y cells seeded with brain extracts from cases of Alzheimer's disease and corticobasal degeneration
- The multifaceted functions of β-arrestins and their therapeutic potential in neurodegenerative diseases
- Brain energetics and glucose transport in metabolic diseases: role in neurodegeneration
- Disrupting pathologic phase transitions in neurodegeneration
- Dissecting Parkinson's disease with long-read RNA-sequencing
- The contribution of DNA methylation to the (dys)function of oligodendroglia in neurodegeneration
- How can we manage progressive supranuclear palsy syndrome with pharmacotherapy?
- Neuropathological hallmarks in autopsied cases with mitochondrial diseases caused by the mitochondrial 3243A>G mutation
- Age-related hearing loss and dementia-related neuropathology: An analysis of the United Kingdom brains for dementia research cohort
- Supercomplex formation of mitochondrial respiratory chain complexes in leukocytes from patients with neurodegenerative diseases
- Refinement of prognostication for IDH-mutant astrocytomas using DNA methylation-based classification
- Ischemia-Reperfusion Programming of Alzheimer's Disease-Related Genes-A New Perspective on Brain Neurodegeneration after Cardiac Arrest
- A comprehensive histomolecular characterization of meningioangiomatosis: Further evidence for a precursor neoplastic lesion
- Purinergic receptors in cognitive disturbances